CIK 0001840877 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Envoy Medical, Inc.
Sign in to watch- Ticker
- COCH
- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 861369123
- Phone
- 651-361-8000
- Business address
- 4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE, MN, 55110
- Former names
- Anzu Special Acquisition Corp I
Securities
- COCH Class A Common Stock Nasdaq
- COCHW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-20 | Patel Mona Chetan Director | Purchase | +2,500 | $2.28 | $6K | 7,500 |
| 2024-11-19 | Kantor Susan Director | Other acquisition | +18,182 | 43,182 | ||
| 2024-11-19 | Anzu SPAC GP I LLC 10% owner | Other disposition | −1,000,000 | 1,000,000 | ||
| 2024-09-11 | Patel Mona Chetan Director | Purchase | +4,000 | $3.33 | $13K | 5,000 |
| 2024-09-09 | Patel Mona Chetan Director | Purchase | +1,000 | $3.20 | $3K | 1,000 |
| 2024-08-27 | TAYLOR GLEN A Director | Grant or award · Warrant (right to buy) | +500,000 | 500,000 | ||
| 2024-08-08 | Crowe Michael Curtis Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2024-07-22 | TAYLOR GLEN A Director | Grant or award · Warrant (right to buy) | +250,000 | 250,000 | ||
| 2024-06-24 | Lucas Brent T. Chief Executive Officer | Other acquisition | +74,784 | 195,615 | ||
| 2024-06-24 | Lucas Brent T. Chief Executive Officer | Other acquisition | +10,176 | 12,720 | ||
| 2024-05-23 | TAYLOR GLEN A Director | Grant or award · Warrant (right to buy) | +250,000 | 250,000 | ||
| 2024-02-27 | TAYLOR GLEN A Director | Purchase · Warrant (right to buy) | +500,000 | 500,000 | ||
| 2023-12-20 | Anzu SPAC GP I LLC 10% owner | Conversion · Series A Preferred Stock, par value $0.0001 per share | −373,333 | 2,126,667 | ||
| 2023-11-21 | Lucas Brent T. Chief Executive Officer | Purchase | +10,000 | $0.98 | $10K | 118,451 |
| 2023-11-21 | Lucas Brent T. Chief Executive Officer | Purchase | +2,380 | $0.92 | $2K | 120,831 |
| 2023-11-20 | TAYLOR GLEN A Director | Other disposition · Series A Preferred Stock | −100,000 | $10.00 | $1.0M | 1,000,000 |
| 2023-11-20 | TAYLOR GLEN A Director | Purchase · Series A Preferred Stock | +100,000 | $10.00 | $1.0M | 1,100,000 |
| 2023-10-15 | Kantor Susan Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2023-10-15 | Lucas Brent T. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +879,749 | 879,749 | ||
| 2023-10-15 | BRYNELSEN CHARLES Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 |
Page 4 of 6 · 103 trades